The U.S. Food and Drug Administration (FDA) issued an emergency use authorization for a blood purification system to treat patients 18 years of age or older with confirmed Coronavirus Disease 2019 (COVID-19) admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure. Read more...
Avacta Group has entered into a collaboration with Cytiva, formerly known as GE Healthcare Life Sciences. Read more...
Lupus Therapeutics announced is embarking on a clinical study to assess the potential benefit of hydroxychloroquine and/or other lupus therapies in preventing or reducing the symptoms of COVID-19 in people with lupus. Read more...
Viriom announced the initiation of a Phase 2 clinical study to evaluate the efficacy of elsulfavirine in adults with moderate manifestations of COVID-19 (novel coronavirus). Read more...